New psoriasis pill shows promise in early safety trial
Symptom relief
Completed
This study tested a new drug called AX-158 in 31 adults with mild to moderate plaque psoriasis. Participants took either AX-158 or a placebo daily for 28 days, then were monitored for another 30 days. The main goal was to see if the drug is safe and tolerable, with some early che…
Phase: PHASE1, PHASE2 • Sponsor: Artax Biopharma Inc • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC